Incidence and survival of primary central nervous system lymphoma (PCNSL): results from the Girona cancer registry (1994-2013)

Clin Transl Oncol. 2018 Dec;20(12):1628-1630. doi: 10.1007/s12094-018-1890-8. Epub 2018 May 23.

R Fuentes-Raspall¹, M Solans^{2

3

4}, C Auñon-Sanz¹, M Saez^{5

6}, R Marcos-Gragera^{6

7

8}

¹ Radiation Oncology Service, Josep Trueta University Hospital, Catalan Institute of Oncology, Girona, Spain.
² Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. [email protected].
³ Research Group on Statistics, Econometrics and Health (GRECS), Universitat de Girona, Carrer de la Universitat de Girona 10, Campus de Montilivi, 17003, Girona, Spain. [email protected].
⁴ Descriptive Epidemiology, Genetics and Cancer Prevention Group, Girona Biomedical Research Institute (IdIBGi), Girona, Spain. [email protected].
⁵ Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
⁶ Research Group on Statistics, Econometrics and Health (GRECS), Universitat de Girona, Carrer de la Universitat de Girona 10, Campus de Montilivi, 17003, Girona, Spain.
⁷ Descriptive Epidemiology, Genetics and Cancer Prevention Group, Girona Biomedical Research Institute (IdIBGi), Girona, Spain.
⁸ Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona, Spain.

No abstract available

Keywords: Incidence; Population-based; Primary central nervous system lymphoma (PCNSL); Spain; Survival.

Publication types